Harness Therapeutics

Developer of a biotechnology platform designed to help the physiological upregulation of important neurodegenerative targets. The company utilizes mRNA-targeted oligonucleotides to modulate post-trans...

Healthcare
Cambridge, United Kingdom
Founded 2020
22 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$23M
Last Round
N/A

Get the full picture

Create a free account to unlock Harness Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required